Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Pacgen, General Biologicals deal

Pacgen will grant General Biologicals exclusive, worldwide rights to develop and commercialize products containing PAC-113 or

Read the full 161 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE